DrugPatentWatch Database Preview
VAZCULEP Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Vazculep, and when can generic versions of Vazculep launch?
Vazculep is a drug marketed by Avadel Legacy and is included in one NDA.
The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
Summary for VAZCULEP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 49 |
| Patent Applications: | 1,437 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VAZCULEP |
| DailyMed Link: | VAZCULEP at DailyMed |
Pharmacology for VAZCULEP
| Drug Class | alpha-1 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha1-Agonists |
Medical Subject Heading (MeSH) Categories for VAZCULEP
Synonyms for VAZCULEP
| (-)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol, hydroc hloride |
| (-)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol, hydrochloride |
| (-)-alpha-Hydroxy-beta-(methylamino)ethyl-alpha-(3-hydroxybenzene) hydrochloride |
| (-)-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol hydrochloride |
| (-)-Phenylephrine hydrochloride |
| (R)-(-)-1-(3-Hydroxyphenyl)-2-methylaminoethanol hydrochloride |
| (R)-(-)-3-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride |
| (R)-(-)-Phenylephrine (hydrochloride) |
| (R)-(-)-Phenylephrine hydrochloride |
| (R)-(-)-Phenylephrine hydrochloride, analytical standard |
| (R)-(-)-Phenylephrine hydrochloride, powder |
| (R)-(-)-Phenylephrine hydrochloride, tested according to Ph.Eur. |
| (R)-3-(1-Hydroxy-2-(methylamino)ethyl)phenol hydrochloride |
| (R)-3-hydroxy-a-[(methylamino)methyl]-benzenemethanol hydrochloride |
| (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol hydrochloride |
| (R)-Phenylephrine hydrochloride |
| 04JA59TNSJ |
| 1-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride |
| 10% phenylephrine HCl cream, Solvay/SLA Pharma |
| 20% phenylephrine HCl cream, Solvay/SLA Pharma |
| 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol hydrochloride |
| 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride |
| 3-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol hydrochloride |
| 50741-76-9 |
| 59-42-7 (Parent) |
| 61-76-7 |
| 644-22-4 |
| 827-62-3 |
| AB2000665 |
| AC1NR4GJ |
| Adrianol |
| Afrin 4 Hour Nasal Spray |
| AK150851 |
| AKOS022190146 |
| Alcon-efrin |
| Almefrin |
| BCP0726000237 |
| Benzedrex Nasal Spray, Regular |
| Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride (1:1), (alphaR)- |
| Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride (R)- |
| Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (-)- |
| Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (alphaR)- |
| Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (-)- |
| Biomydrin |
| C9H13NO2.HCl |
| CAS-61-76-7 |
| CCG-39113 |
| CCRIS 219 |
| CHEBI:8094 |
| CHEMBL1200339 |
| Consdrin |
| Consdrin hydrochloride |
| CS-2585 |
| D-(-)-Phenylephrine hydrochloride |
| D00511 |
| D0D7QO |
| DSSTox_CID_1142 |
| DSSTox_GSID_21142 |
| DSSTox_RID_75972 |
| DTXSID3021142 |
| Efricel |
| EINECS 200-517-3 |
| Emagrin |
| EU-0100920 |
| Fenilfar |
| Fenox |
| GL9617 |
| Histabid |
| HMS1920H08 |
| HY-B0471 |
| Idrianol |
| Incostop |
| Isophrin hydrochloride |
| l-1-(m-Hydroxyphenyl)-2-methyl-aminoethanol hydrochloride |
| L-Pheny lephrine Hydrochloride |
| L-PHENYLEPHRINE HYDROCHLORIDE |
| Levophenylephrine hydrochloride |
| Lexatol |
| LP00920 |
| LS-1454 |
| m-Methylaminoethanolphenol hydrochloride |
| meta-Sympatol |
| meta-Synephrine hydrochloride |
| Metaoxedrine chloride |
| Metaoxedrine hydrochloride |
| MFCD00012605 |
| MLS000069696 |
| MLS006012005 |
| MolPort-003-666-260 |
| Mydfrin |
| NCGC00024257-04 |
| NCGC00024257-08 |
| NCGC00094231-01 |
| NCGC00256496-01 |
| NCGC00258813-01 |
| NCGC00261605-01 |
| NCI-C55641 |
| Neo-Synephrine (TN) |
| Neo-Synesin 1 |
| Neooxedrine chloride |
| Neophryn |
| Neosympatol |
| Neosynephrine hydrochloride |
| neosynephrine hydrocholride |
| NSC-757273 |
| NSC757273 |
| OCYSGIYOVXAGKQ-FVGYRXGTSA-N |
| Oftalfrine |
| OP-Isophrin |
| Op-Isophrin-Z |
| Opera_ID_1786 |
| P 6126 |
| P0398 |
| Pharmakon1600-01500483 |
| Phenistan |
| Phenylephrine HCl |
| PHENYLEPHRINE HYDROCHLORIDE |
| Phenylephrine hydrochloride (JP17/USP) |
| Phenylephrine hydrochloride [USAN:JAN] |
| Phenylephrine hydrochloride [USP:JAN] |
| Phenylephrine hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Phenylephrine hydrochloride gel |
| Phenylephrine hydrochloride gel (fecal incontinence) |
| Phenylephrine hydrochloride gel (fecal incontinence), SLA Pharma/Ventrus Biosciences |
| Phenylephrine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Phenylephrine hydrochloride, l- |
| Phenylephrine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Phenylephrine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Phenylephrine.HCl |
| Phenylephrinehydrochloride |
| Prefrin |
| PubChem23988 |
| Pyristan |
| Q-201561 |
| R-(-)-m-Synephrine hydrochloride |
| Relief |
| Rhinall |
| s2569 |
| SCHEMBL24654 |
| SMR000058497 |
| SPECTRUM1500483 |
| SR-01000075286 |
| SR-01000075286-1 |
| ST24035423 |
| Stanephrin |
| Sucraphen |
| Sudafed PE |
| Synasal |
| Synethenate |
| Tox21_110897 |
| Tox21_110897_1 |
| Tox21_201261 |
| Tox21_302846 |
| Tox21_500920 |
| UNII-04JA59TNSJ |
| UNII-O2VT86KV7E component OCYSGIYOVXAGKQ-FVGYRXGTSA-N |
| Vasosulf |
| VEN-308 |
| Vicks Sinex Nasal Spray |
| Vicks Sinex Vapospray |
| VU0239753-6 |
US Patents and Regulatory Information for VAZCULEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-001 | Jun 27, 2014 | AP | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-002 | Jun 27, 2014 | AP | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-003 | Jun 27, 2014 | AP | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
